Page 11 - Functional Capacity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OHCHR | Committee on Economic, Social And Cultural Rights discusses the effects of the COVID-19 pandemic in its dialogue with Finland

19 February 2021 The Committee on Economic, Social and Cultural Rights concluded today its review of the seventh periodic report of Finland on measures taken to implement the provisions of the International Covenant on Economic, Social and Cultural Rights. Addressing the COVID-19 pandemic, Committee Experts asked the delegation to comment on the impact of the emergency measures on economic, social and cultural rights, notably how they affected minority groups, immigrants, refugees and asylum seekers.  What was the practice of Finland to share its resources related to vaccination with other countries that lacked resources?  Would Finland support the proposal to waiver intellectual property rights to facilitate the access to vaccines in the Global South?

Michael windfuhrKrista oinonenMikel mancisidorMinistry of foreign affairs finlandUnited nations office at genevaInternational labour organizationClient charges in healthHealth services for older personsInternational labour organization conventionMinistry of the environmentCommittee expertsCommittee on economicNational action plan on fundamental rightsMinistry of justiceEuropean unionEuropean committee of social rights

Lukijan mielipide: Joka kunta haluaa toimintakuntoisia kuntalaisia

Lukijan mielipide: Joka kunta haluaa toimintakuntoisia kuntalaisia
kainuunsanomat.fi - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kainuunsanomat.fi Daily Mail and Mail on Sunday newspapers.

Functional capacityFairy tale executiveசெயல்பாட்டு திறன்

Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks

Date Time Elderly esophageal cancer patients often receive suboptimal therapy due to perceived risks Older patients who do receive recommended multimodal therapy, including surgery, have outcomes comparable with those of younger patients CHICAGO: Elderly patients (70 years and over) with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer (located in the stomach and esophagus) should be considered for optimal therapy that has the potential to cure. This therapy regimen includes initial chemoradiotherapy (NACR) and surgical resection, an operation that removes the cancerous part of the organ. According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen. In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old). The single-institution study from the Ochsner Clinic

United statesXinyi luoClin gastroenterol hepatolNathanm boltonJohns boltonRussell brownAndrewm welchW peter sawyerOchsner clinical schoolSouthern surgical association programUniversity of queenslandOchsner clinic foundationJournal of the american college surgeonsDepartment of surgeryInternational trends in incidenceAmerican college of surgeons

Prilenia Enrolls First Subject in Europe in its PROOF-HD Phase 3 Clinical Trial for Huntington s Disease

Prilenia Enrolls First Subject in Europe in its PROOF-HD Phase 3 Clinical Trial for Huntington s Disease About Prilenia (www.prilenia.com) Prilenia is a clinical stage biotech startup founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders. Prilenia raised 88.5 million thus far and is backed by a group of well-respected investors: Talisman, Forbion, Morningside and Sectoral and ALS Investment Fund. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S. About Pridopidine Prilenia s lead asset is Pridopidine, a first-in-class drug candidate with an established safety profile and therapeutic potential in several neurodegenerative diseases affecting adults and children. The highly selective S1R agonist was acquired from Teva in 2018.

United statesUnited kingdomNorth lanarkshireCzech republicTel avivNoord hollandKostenloser wertpapierhandelLimor ben harRalf reilmannMichaelr haydenHuntington study groupGeorge huntington instituteInvestment fundEuropean huntington disease networkHuntington study group clinical researchClinical research inc

Minerals aid brain health, aging | Natural Products INSIDER

According to U.S. Census Bureau estimates, by 2030, 1 in 5 residents will be retirement age. As the senior population over the age of 65 continues to grow through the years, so will age-related cognitive health issues. The Institute of Medicine’s (IOM) book “Cognitive Aging” notes that years of research have shown age debilitates cognitive abilities such as attention, memory and visuospatial function. Changes in the brain have actually been shown to begin happening as early as age 20. 1CDC data in a brief on subjective cognitive decline indicated it has become a growing public health issue, with signs of cognitive decline showing up among 11.1% of individuals 45 years of age and older, affecting approximately 1 in 9 adults. The current pandemic has significantly curtailed social interactions which some consider an essential activity for cognitive enrichment particularly in aging populations

Stephen ashmeadSara adaesInstitute of medicineJ nutr healthBalchem corpUs census bureauEnrichment effects on adult cognitive developmentNutrition business journalAdult cognitive developmentFunctional capacityOlder adults be preservedSci publicSystematic reviewMed resBrain diseasesPotential treatment